Biogen Inc.
BIIB
$199.36
$1.410.71%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.23% | 2.22% | 4.77% | 3.36% | 1.59% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.23% | 2.22% | 4.77% | 3.36% | 1.59% |
| Cost of Revenue | -5.79% | -4.13% | -3.43% | -2.88% | 12.41% |
| Gross Profit | 3.85% | 4.53% | 7.91% | 5.82% | -1.93% |
| SG&A Expenses | 3.60% | 1.89% | 4.87% | -3.11% | -3.83% |
| Depreciation & Amortization | 26.62% | 31.20% | 38.14% | 52.13% | 56.31% |
| Other Operating Expenses | 24.06% | 14.07% | 10.25% | 11.47% | 8.62% |
| Total Operating Expenses | 0.30% | -0.54% | 1.26% | -2.90% | -5.99% |
| Operating Income | 3.82% | 9.86% | 14.69% | 24.95% | 30.66% |
| Income Before Tax | -7.38% | -18.34% | -0.11% | 36.82% | 32.43% |
| Income Tax Expenses | -8.06% | -3.73% | 1.30% | 70.95% | 75.06% |
| Earnings from Continuing Operations | -7.26% | -20.79% | -0.37% | 32.21% | 26.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.26% | -20.79% | -0.41% | 32.10% | 26.80% |
| EBIT | 3.82% | 9.86% | 14.69% | 24.95% | 30.66% |
| EBITDA | 5.78% | 11.11% | 16.02% | 26.05% | 31.31% |
| EPS Basic | -7.87% | -21.28% | -1.04% | 31.43% | 26.09% |
| Normalized Basic EPS | 4.84% | 13.24% | 18.87% | 25.38% | 26.94% |
| EPS Diluted | -7.95% | -21.24% | -1.01% | 31.58% | 26.31% |
| Normalized Diluted EPS | 4.80% | 13.33% | 18.98% | 25.48% | 27.16% |
| Average Basic Shares Outstanding | 0.67% | 0.64% | 0.60% | 0.60% | 0.60% |
| Average Diluted Shares Outstanding | 0.72% | 0.53% | 0.50% | 0.55% | 0.48% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |